Title : hTERT promotes imatinib resistance in chronic myeloid leukemia cells: therapeutic implications.

Pub. Date : 2011 May

PMID : 21364010






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 hTERT promotes imatinib resistance in chronic myeloid leukemia cells: therapeutic implications. Imatinib Mesylate telomerase reverse transcriptase Homo sapiens
2 We showed that sensitivity to imatinib can be partly restored in imatinib-resistant cells by targeting telomerase expression, either by the introduction of a dominant-negative form of the catalytic protein subunit of the telomerase (hTERT) or by the treatment with all-trans-retinoic acid, a clinically used drug. Imatinib Mesylate telomerase reverse transcriptase Homo sapiens
3 Furthermore, we showed that hTERT overexpression favors the development of imatinib resistance through both its antiapoptotic and telomere maintenance functions. Imatinib Mesylate telomerase reverse transcriptase Homo sapiens